Characterization and outcome following excision of masses in the nictitating membranes of horses: 50 cases (1998-2012)

Nicole M. Scherrer, Mary Utter, Brianna C. McKenna

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Results—Squamous cell carcinoma was the predominant tumor type of the third eyelid. There was recurrence in 10 of 50 (20%) horses; recurrence was at a mean of 2.25 years and median of 1.5 years after excision. Partial excision prior to referral was associated with outcome.Conclusions and Clinical Relevance—In horses with masses in a third eyelid, recurrence and mortality rates were high, which suggested that long-term monitoring is important for all patients in which partial or complete third eyelid excision is performed.

Objective—To determine the histologic findings associated with masses in the nictitating membranes (third eyelids) of horses and to identify prognostic factors associated with recurrence and the outcome.

Design—Retrospective case series.

Animals—50 horses with masses in a third eyelid.

Procedures—Medical records of horses with partial or complete excision of a third eyelid and submission for histologic evaluation between September 1998 and November 2012 were reviewed. Horses were included if follow-up information for at least 1 year after sur- gery was available. Information regarding signalment and treatment was obtained from the medical records. Histopathology reports were examined to determine surgical margins and vascular invasion. Data were analyzed by means of a 2 test to determine the association between recurrence and type of excision (partial or complete), surgical margins, vascular invasion, and use of chemotherapy as well as the association between partial excision of a third eyelid prior to referral and outcome.

Original languageEnglish (US)
Pages (from-to)812-815
Number of pages4
JournalJournal of the American Veterinary Medical Association
Volume245
Issue number7
DOIs
StatePublished - Jan 1 2014
Externally publishedYes

Fingerprint

Nictitating Membrane
eyelids
Horses
horses
Recurrence
blood vessels
Blood Vessels
Referral and Consultation
excision
histopathology
drug therapy
carcinoma
Medical Records
surgery
neoplasms
Carcinoma
monitoring
Drug Therapy
Mortality

ASJC Scopus subject areas

  • veterinary(all)

Cite this

Characterization and outcome following excision of masses in the nictitating membranes of horses : 50 cases (1998-2012). / Scherrer, Nicole M.; Utter, Mary; McKenna, Brianna C.

In: Journal of the American Veterinary Medical Association, Vol. 245, No. 7, 01.01.2014, p. 812-815.

Research output: Contribution to journalArticle

@article{ee6d4dbdd1e54a588d2c9583ff8c506b,
title = "Characterization and outcome following excision of masses in the nictitating membranes of horses: 50 cases (1998-2012)",
abstract = "Results—Squamous cell carcinoma was the predominant tumor type of the third eyelid. There was recurrence in 10 of 50 (20{\%}) horses; recurrence was at a mean of 2.25 years and median of 1.5 years after excision. Partial excision prior to referral was associated with outcome.Conclusions and Clinical Relevance—In horses with masses in a third eyelid, recurrence and mortality rates were high, which suggested that long-term monitoring is important for all patients in which partial or complete third eyelid excision is performed.Objective—To determine the histologic findings associated with masses in the nictitating membranes (third eyelids) of horses and to identify prognostic factors associated with recurrence and the outcome.Design—Retrospective case series.Animals—50 horses with masses in a third eyelid.Procedures—Medical records of horses with partial or complete excision of a third eyelid and submission for histologic evaluation between September 1998 and November 2012 were reviewed. Horses were included if follow-up information for at least 1 year after sur- gery was available. Information regarding signalment and treatment was obtained from the medical records. Histopathology reports were examined to determine surgical margins and vascular invasion. Data were analyzed by means of a 2 test to determine the association between recurrence and type of excision (partial or complete), surgical margins, vascular invasion, and use of chemotherapy as well as the association between partial excision of a third eyelid prior to referral and outcome.",
author = "Scherrer, {Nicole M.} and Mary Utter and McKenna, {Brianna C.}",
year = "2014",
month = "1",
day = "1",
doi = "10.2460/javma.245.7.812",
language = "English (US)",
volume = "245",
pages = "812--815",
journal = "Journal of the American Veterinary Medical Association",
issn = "0003-1488",
publisher = "American Veterinary Medical Association",
number = "7",

}

TY - JOUR

T1 - Characterization and outcome following excision of masses in the nictitating membranes of horses

T2 - 50 cases (1998-2012)

AU - Scherrer, Nicole M.

AU - Utter, Mary

AU - McKenna, Brianna C.

PY - 2014/1/1

Y1 - 2014/1/1

N2 - Results—Squamous cell carcinoma was the predominant tumor type of the third eyelid. There was recurrence in 10 of 50 (20%) horses; recurrence was at a mean of 2.25 years and median of 1.5 years after excision. Partial excision prior to referral was associated with outcome.Conclusions and Clinical Relevance—In horses with masses in a third eyelid, recurrence and mortality rates were high, which suggested that long-term monitoring is important for all patients in which partial or complete third eyelid excision is performed.Objective—To determine the histologic findings associated with masses in the nictitating membranes (third eyelids) of horses and to identify prognostic factors associated with recurrence and the outcome.Design—Retrospective case series.Animals—50 horses with masses in a third eyelid.Procedures—Medical records of horses with partial or complete excision of a third eyelid and submission for histologic evaluation between September 1998 and November 2012 were reviewed. Horses were included if follow-up information for at least 1 year after sur- gery was available. Information regarding signalment and treatment was obtained from the medical records. Histopathology reports were examined to determine surgical margins and vascular invasion. Data were analyzed by means of a 2 test to determine the association between recurrence and type of excision (partial or complete), surgical margins, vascular invasion, and use of chemotherapy as well as the association between partial excision of a third eyelid prior to referral and outcome.

AB - Results—Squamous cell carcinoma was the predominant tumor type of the third eyelid. There was recurrence in 10 of 50 (20%) horses; recurrence was at a mean of 2.25 years and median of 1.5 years after excision. Partial excision prior to referral was associated with outcome.Conclusions and Clinical Relevance—In horses with masses in a third eyelid, recurrence and mortality rates were high, which suggested that long-term monitoring is important for all patients in which partial or complete third eyelid excision is performed.Objective—To determine the histologic findings associated with masses in the nictitating membranes (third eyelids) of horses and to identify prognostic factors associated with recurrence and the outcome.Design—Retrospective case series.Animals—50 horses with masses in a third eyelid.Procedures—Medical records of horses with partial or complete excision of a third eyelid and submission for histologic evaluation between September 1998 and November 2012 were reviewed. Horses were included if follow-up information for at least 1 year after sur- gery was available. Information regarding signalment and treatment was obtained from the medical records. Histopathology reports were examined to determine surgical margins and vascular invasion. Data were analyzed by means of a 2 test to determine the association between recurrence and type of excision (partial or complete), surgical margins, vascular invasion, and use of chemotherapy as well as the association between partial excision of a third eyelid prior to referral and outcome.

UR - http://www.scopus.com/inward/record.url?scp=84907185318&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84907185318&partnerID=8YFLogxK

U2 - 10.2460/javma.245.7.812

DO - 10.2460/javma.245.7.812

M3 - Article

C2 - 25229533

AN - SCOPUS:84907185318

VL - 245

SP - 812

EP - 815

JO - Journal of the American Veterinary Medical Association

JF - Journal of the American Veterinary Medical Association

SN - 0003-1488

IS - 7

ER -